Can a fitness tracker get young cancer patients moving?
NCT ID NCT06182163
First seen Nov 01, 2025 · Last updated Jun 08, 2026 · Updated 29 times
Summary
This study tested whether a mobile health program—including a fitness tracker with reminders to move, coaching, and an app-based support group—could help 20 teens and young adults (ages 12-21) with acute lymphoblastic leukemia (ALL) reduce the time they spend sitting or lying down during maintenance chemotherapy. The program lasted 10 weeks, and researchers measured if it was feasible and acceptable, and if it showed signs of improving quality of life and reducing inflammation. All participants continued their regular chemo visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.